Atopic dermatitis incidence and risk factors in young adults in Castellon (Spain): A prospective cohort study

Main Article Content

A. Arnedo-Pena
J. Puig-Barberà
A. Artero-Civera
M.A. Romeu-Garcia
N. Meseguer-Ferrer
C. Fenollosa-Amposta
A. Vizcaino-Batllés
E. Silvestre-Silvester
M.R. Pac-Sa
L. Segura-Navas
M.A. Dubón
J. Fabregat-Puerto
J.B. Bellido-Blasco

Keywords

Atopic dermatitis, Cohort, Incidence, Young adults, Risk factors

Abstract

Introduction: There are few atopic dermatitis (AD) incidence cohort studies in young adults, the etiology of this disease remains obscure, and AD risk factors in adults are not well understood. The objective of this study was to estimate AD ten-year incidence and prevalence in a cohort of adolescent aged 14-16 at inception in Castellon province in Valencia Region, Spain and describe related risk factors.


Material and methods: From 2002 to 2012, a population-based prospective cohort study was carried out. Questionnaires from the International Study of Asthma and Allergies in Childhood (ISAAC) were used with an additional questionnaire correlated factors completed by participants and their parents, respectively, in 2002. In 2012 the same questionnaires were completed by the participants’ through a telephone interview, and incidence and prevalence of AD were estimated. Directed acyclic graphs, Poisson regression and inverse probability weighted regression adjustment were used.


Results: The participation rate was 79.5% (1435/1805) with AD lifetime prevalence of 34.9% and AD incidence of 13.5 per 1000 person-years. Females presented higher prevalence and incidence than males. After adjustment significant risk factors were being female, history of asthma or allergic rhinitis, family history of AD, history of respiratory infections, history of bronchitis, history of pneumonia, history of sinusitis, and birthplace outside Castellon province. The highest AD population attributable risks were female, 30.3%, and history of respiratory infections 15.3%. Differences with AD childhood risk factors were found.


Conclusions: AD incidence in our cohort was high and several risks factors were related to AD.

Abstract 123 | PDF Downloads 109

References

1. Serra-Baldrich E, de Frutos JO, Jáuregui I, Armario-Hita JC, Silvestre JF, Herraez L, et al. Changing perspectives in atopic dermatitis. Allergol Immunopathol (Madr). 2018;46:397-412.

2. Silvestre-Salvador JF, Romero-Pérez D, Encabo-Durán B. Atopic dermatitis in adults: a diagnostic challenge. J Investig Allergol Clin Immunol. 2017;27:78-88.

3. Deckers I, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A. Investigating international time trends in the incidence and prevalence of atopic eczema 1990---2010: a systematic review of epidemiological studies. PLoS ONE. 2012;7:e39803.

4. Peters AS, Kellberger J, Vogelberg C, Dressel H, Windstetter D, Weinmayr G, et al. Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study. J Allergy Clin Immunol. 2010;126:590-5.

5. Mortz CG, Andersen KE, Dellgren C, Barington T, BindslevJensen C. Atopic dermatitis from adolescence to adulthood on the TOACS cohort: prevalence, persistence and comorbidities. Allergy. 2015;70:836-45.

6. Gough H, Grabenhenrich L, Reich A, Eckers N, Nitsche O, Schramm D, et al. Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS. Pediatr Allergy Immunol. 2015;26:431-7.

7. Henriksen L, Simonsen J, Haerskjold A, Linder M, Kieler H, Thomsen SF, et al. Incidence rates of atopic dermatitis, asthma, and allergic rhinoconjunctivitis in Danish and Swedish children. J Allergy Clin Immunol. 2015;136:360-6.

8. Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy. 2014;69:3-16.

9. Bonamonte D, Filoni A, Vestita M, Romita P, Foti C, Angelini G. The role of the environmental risk factors in the pathogenesis and clinical outcome of atopic dermatitis. Biomed Res Int. 2019;2019:2450605.

10. Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73: 1284-93.

11. Williams HC. Epidemiology of human atopic dermatitis-seven areas of notable progress and seven areas of notable ignorance.
Vet Dermatol. 2013;24:3-9.

12. Segura-Navas L, Arnedo-Pena A, Tosca-Segura R, Romeu-García MA, Meseguer-Ferrer N, Silvestre-Silvestre E, et al. Incidence of asthma in young adults from Castellon, Spain: a prospective cohort study. Allergol Immunopathol (Madr). 2018;46:112-8.

13. Textor J, van der Zander B, Gilthorpe MS, Liskiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package‘dagitty’. Int J Epidemiol. 2016;45:1887-94.

14. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10:37-48.

15. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656-64. PMC2732954.

16. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health. 1998;88:15-9.

17. Finnbogadóttir AF, Árdal B, Eiríksson H, Hrafnkelsson B, Valdimarsson H, Lúðvíksson BR, et al. A long-term followup of allergic diseases in Iceland. Pediatr Allergy Immunol. 2012;23:181-5.

18. Abuabara K, Ye M, McCulloch CE, Sullivan A, Margolis DJ, Strachan DP, et al. Clinical onset of atopic eczema: results from 2 nationally representative British birth cohorts followed through midlife. J Allergy Clin Immunol. 2019;144:710-9.

19. Arnedo-Pena A. Prevalencia de rinitis alérgica y eczema atópico en población escolar de Castelló. Pamplona: Departamento de
Ciencias de la Salud Universidad Pública de Navarra Tesis doctoral; 1999.

20. Tham EH, Loo EXL, Zhu Y, Shek LP. Effects of migration on allergic diseases. Int Arch Allergy Immunol. 2019;178:128-40.

21. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70:338-51.

22. Mukherjee N, Sutter TR, Arshad SH, Holloway JW, Zhang H, Karmaus W. Breastfeeding duration modifies the effect of smoking during pregnancy on eczema from early childhood to adolescence. Clin Exp Allergy. 2018;48:1688-97.

23. Chatenoud L, Bertuccio P, Turati F, Galeone C, Naldi L, Chatenoud L, et al. Allergy. 2019, http://dx.doi.org/10.1111/all.13990.

24. Tsakok T, McKeever TM, Yeo L, Flohr C. Does early life exposure to antibiotics increase the risk of eczema? A systematic review. Br J Dermatol. 2013;169:983-91.

25. Do˘gruel D, Bingöl G, Altıntas¸ DU, Yılmaz M, Kendirli SG. Prevalence of and risk factors for atopic dermatitis: a birth cohort study of infants in southeast Turkey. Allergol Immunopathol (Madr). 2016;44:214-20.

26. Benn CS, Melbye M, Wohlfahrt J, Björkstén B, Aaby P. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ. 2004;328:1223.

27. Lee ZM, Huang YH, Ho SC, Kuo HC. Correlation of symptomatic enterovirus infection and later risk of allergic diseases via a population-based cohort study. Medicine (Baltimore). 2017;96:e5827.

28. Pembrey L, Waiblinger D, Griffiths P, Wright J. Age at cytomegalovirus, Epstein Barr virus and varicella zoster virus infection and risk of atopy: the Born in Bradford cohort, UK. Pediatr Allergy Immunol. 2019;30:604-13.

29. Meylan P, Lang C, Mermoud S, Johannsen A, Norrenberg S, Hohl D, et al. Skin colonization by staphylococcus aureus precedes the clinical diagnosis of atopic dermatitis in infancy. J Invest Dermatol. 2017;137:2497-504.

30. Cramer C, Link E, Horster M, Koletzko S, Bauer CP, Berdel D, et al. Elder siblings enhance the effect of filaggrin mutations on childhood eczema: results from the 2 birth cohort studies LISAplus and GINIplus. J Allergy Clin Immunol. 2010;125:1254-60.

31. Langan SM, Abuabara K, Henrickson SE, Hoffstad O, Margolis DJ. Increased risk of cutaneous and systemic infections in atopic dermatitis: a Cohort study. J Invest Dermatol. 2017;137:1375-7.

32. Sacotte R, Silverberg JI. Epidemiology of adult atopic dermatitis. Clin Dermatol. 2018;36:595---605.

33. Kantor R, Kim A, Thyssen JP, Silverberg JI. Association of atopic dermatitis with smoking: a systematic review and metaanalysis. J Am Acad Dermatol. 2016;75:1119-25.

34. Schnass W, Hüls A, Vierkötter A, Krämer U, Krutmann J, Schikowski T. Traffic-related air pollution and eczema in the elderly: findings from the SALIA cohort. Int J Hyg Environ Health. 2018;221:861-7.

35. Arnedo-Pena A, Bellido-Blasco J, Puig-Barbera J, Artero-Civera A, Campos-Cruanes ˜ JB, Pac-Sa MR, et al. Dureza del agua de consumo doméstico y prevalencia de eczema atópico en escolares de Castellón, Espana. ˜ Salud Publica Mex. 2007;49:295-301.

36. Perkin MR, Craven J, Logan K, et al. Association between domestic water hardness, chlorine, and atopic dermatitis risk in early life: a population-based cross-sectional study. J Allergy Clin Immunol. 2016;138:509-16.

37. Engebretsen KA, Bager P, Wohlfahrt J, Skov L, Zachariae C, Nybo-Andersen AM, et al. Prevalence of atopic dermatitis in infants by domestic water hardness and season of birth: Cohort study. J Allergy Clin Immunol. 2017;139:1568-74.

38. Stenberg B, Lindberg M, Meding B, Svensson A. Is the question ‘Have you had childhood eczema?’ useful for assessing childhood atopic eczema in adult population surveys. Contact Dermatitis. 2006;54:334-7.

39. Silverberg JI, Patel N, Immaneni S, Rusniak B, Silverberg NB, Debashis R, et al. Assessment of atopic dermatitis using selfreport and caregiver report: a multicenter validation study. Br J Dermatol. 2015;173:1400-4.

40. Ghosh D, Bernstein JA, Khurana Hershey GK, Rothenberg ME, Mersha TB. Leveraging multilayered ‘‘omics’’ data for atopic dermatitis: a road map to precision medicine. Front Immunol. 2018;9:2727.